J. J. FINKELSTEIN - 30 Jun 2021 Form 4 Insider Report for REGENERX BIOPHARMACEUTICALS INC (RGRX)

Role
President and CEO, Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for J.J. Finkelstein pursuant to Power of Attorney previously filed.
Issuer symbol
RGRX
Transactions as of
30 Jun 2021
Net transactions value
+$15,000
Form type
4
Filing time
06 Jul 2021, 16:35:06 UTC
Next filing
04 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGRX Common Stock Purchase $15,000 +75,000 +4.6% $0.2000* 1,712,991 30 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGRX Series A Common Stock Warrant (right to buy) Purchase $0 +56,250 $0.000000 56,250 30 Jun 2021 Common Stock 56,250 $0.2400 Direct
transaction RGRX Series B Common Stock Warrant (right to buy) Purchase $0 +56,250 $0.000000 56,250 30 Jun 2021 Common Stock 56,250 $0.2800 Direct
holding RGRX Stock Option (right to buy) 500,000 30 Jun 2021 Common Stock 500,000 $0.3600 Direct F1
holding RGRX Stock Option (right to buy) 200,000 30 Jun 2021 Common Stock 200,000 $0.6400 Direct F1
holding RGRX Stock Option (right to buy) 150,000 30 Jun 2021 Common Stock 150,000 $0.2800 Direct F1
holding RGRX Stock Option (right to buy) 250,000 30 Jun 2021 Common Stock 250,000 $0.2100 Direct F2
holding RGRX Stock Option (right to buy) 650,000 30 Jun 2021 Common Stock 650,000 $0.2100 Direct F3
holding RGRX Stock Option (right to buy) 500,000 30 Jun 2021 Common Stock 500,000 $0.3000 Direct F4
holding RGRX Convertible Promissory Note (right to buy) $12,500 30 Jun 2021 Common Stock 104,167 $0.1200 Direct
holding RGRX Convertible Promissory Note (right to buy) $12,500 30 Jun 2021 Common Stock 104,167 $0.1200 Direct
holding RGRX Convertible Promissory Note (right to buy) $10,000 30 Jun 2021 Common Stock 27,840 $0.3600 Direct
holding RGRX Common Stock Warrant (right to buy) 78,125 30 Jun 2021 Common Stock 78,125 $0.1800 Direct
holding RGRX Common Stock Warrant (right to buy) 78,125 30 Jun 2021 Common Stock 78,125 $0.1800 Direct
holding RGRX Common Stock Warrant (right to buy) 20,880 30 Jun 2021 Common Stock 20,880 $0.4500 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% vested.
F2 62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
F3 162,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
F4 125,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.